Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

Zymeworks (ZYME) Enterprise Value (2021 - 2025)

Zymeworks' Enterprise Value history spans 3 years, with the latest figure at -$295.4 million for Q3 2023.

  • For Q3 2023, Enterprise Value fell 77.7% year-over-year to -$295.4 million; the TTM value through Sep 2023 reached -$295.4 million, down 77.7%, while the annual FY2022 figure was -$492.2 million, 94.86% down from the prior year.
  • Enterprise Value for Q3 2023 was -$295.4 million at Zymeworks, up from -$340.1 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$166.2 million in Q3 2022 and bottomed at -$492.2 million in Q4 2022.
  • The 3-year median for Enterprise Value is -$317.7 million (2023), against an average of -$314.6 million.
  • The largest annual shift saw Enterprise Value crashed 94.86% in 2022 before it crashed 77.7% in 2023.
  • A 3-year view of Enterprise Value shows it stood at -$252.6 million in 2021, then plummeted by 94.86% to -$492.2 million in 2022, then skyrocketed by 39.99% to -$295.4 million in 2023.
  • Per Business Quant, the three most recent readings for ZYME's Enterprise Value are -$295.4 million (Q3 2023), -$340.1 million (Q2 2023), and -$340.8 million (Q1 2023).